CLDL1 - Overview: Cholesterol, Low-Density Lipoprotein (LDL), Calculated, Serum

Calculation of low-density lipoprotein cholesterol using total cholesterol, non-high-density lipoprotein (HDL) cholesterol, HDL cholesterol, and triglyceride concentrations Managing atherosclerotic cardiovascular disease risk

C3 - Overview: Complement C3, Serum

Assessing disease activity in systemic lupus erythematosus Investigating an undetectable total complement level

CIFS - Overview: Cutaneous Immunofluorescence Antibodies, IgG, Serum

Confirming the presence of IgG antibodies to diagnose of pemphigoid, pemphigus, epidermolysis bullosa acquisita, or bullous lupus erythematosus

C4 - Overview: Complement C4, Serum

Investigating an undetectable total complement Confirming hereditary angioedema (with low C1 inhibitor) Assessing disease activity in systemic lupus erythematosus, proliferative glomerulonephritis, rheumatoid arthritis, and autoimmune...

A2PI - Overview: Alpha-2 Plasmin Inhibitor, Plasma

Diagnosing congenital alpha-2 plasmin inhibitor deficiencies (rare) Providing a complete assessment of disseminated intravascular coagulation, intravascular coagulation and fibrinolysis, or hyperfibrinolysis (primary fibrinolysis), when...

CARU - Overview: Cyclic Adenosine Monophosphate (cAMP), Urinary Excretion, Serum and Urine

Differential diagnosis of hypercalcemia As an adjunct to serum parathyroid hormone measurements, especially in the diagnosis of parathyroid hormone resistance states, such as pseudohypoparathyroidism

CA19 - Overview: Carbohydrate Antigen 19-9 (CA 19-9), Serum

As a potential adjunct for diagnosis and monitoring of pancreatic cancer Potentially differentiating patients with cholangiocarcinoma and primary sclerosing cholangitis (PSC) from those with PSC alone

MMLYP - Overview: Antimicrobial Susceptibility Panel, Yeast, Varies

Determining in vitro quantitative antifungal susceptibility (minimum inhibitory concentration) of non-fastidious yeast As an aid in the management of certain circumstances, such as: -Refractory oropharyngeal infections due to Candida...

BRIVA - Overview: Brivaracetam, Plasma

Assessing compliance and toxicity for brivaracetam

CD43 - Overview: CD43 Immunostain, Technical Component Only

Identification of T lymphocytes, monocytes, macrophages, granulocytes, plasma cells, and a subset of B lymphocytes